161 related articles for article (PubMed ID: 36039426)
21. miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer.
Yu J; Xie F; Bao X; Chen W; Xu Q
Mol Cancer; 2014 May; 13():121. PubMed ID: 24885626
[TBL] [Abstract][Full Text] [Related]
22. A Cell-Fate Reprogramming Strategy Reverses Epithelial-to-Mesenchymal Transition of Lung Cancer Cells While Avoiding Hybrid States.
Kim N; Hwang CY; Kim T; Kim H; Cho KH
Cancer Res; 2023 Mar; 83(6):956-970. PubMed ID: 36710400
[TBL] [Abstract][Full Text] [Related]
23. Transcriptome profiling reveals novel gene expression signatures and regulating transcription factors of TGFβ-induced epithelial-to-mesenchymal transition.
Du L; Yamamoto S; Burnette BL; Huang D; Gao K; Jamshidi N; Kuo MD
Cancer Med; 2016 Aug; 5(8):1962-72. PubMed ID: 27318801
[TBL] [Abstract][Full Text] [Related]
24. Roles of Dietary Phytoestrogens on the Regulation of Epithelial-Mesenchymal Transition in Diverse Cancer Metastasis.
Lee GA; Hwang KA; Choi KC
Toxins (Basel); 2016 May; 8(6):. PubMed ID: 27231938
[TBL] [Abstract][Full Text] [Related]
25. Polyphyllin I Overcomes EMT-Associated Resistance to Erlotinib in Lung Cancer Cells via IL-6/STAT3 Pathway Inhibition.
Lou W; Chen Y; Zhu KY; Deng H; Wu T; Wang J
Biol Pharm Bull; 2017 Aug; 40(8):1306-1313. PubMed ID: 28515374
[TBL] [Abstract][Full Text] [Related]
26. Proteomics analysis reveals the role of ubiquitin specific protease (USP47) in Epithelial to Mesenchymal Transition (EMT) induced by TGFβ2 in breast cells.
Silvestrini VC; Thomé CH; Albuquerque D; de Souza Palma C; Ferreira GA; Lanfredi GP; Masson AP; Delsin LEA; Ferreira FU; de Souza FC; de Godoy LMF; Aquino A; Carrilho E; Panepucci RA; Covas DT; Faça VM
J Proteomics; 2020 May; 219():103734. PubMed ID: 32201364
[TBL] [Abstract][Full Text] [Related]
27. DS-1 Inhibits Migration and Invasion of Non-small-cell Lung Cancer Cells Through Suppression of Epithelial to Mesenchymal Transition and Integrin β1/FAK Signaling.
Putri HE; Sritularak B; Chanvorachote P
Anticancer Res; 2021 Jun; 41(6):2913-2923. PubMed ID: 34083282
[TBL] [Abstract][Full Text] [Related]
28. Small cell lung cancer, an epithelial to mesenchymal transition (EMT)-like cancer: significance of inactive Notch signaling and expression of achaete-scute complex homologue 1.
Ito T; Kudoh S; Ichimura T; Fujino K; Hassan WA; Udaka N
Hum Cell; 2017 Jan; 30(1):1-10. PubMed ID: 27785690
[TBL] [Abstract][Full Text] [Related]
29. The Nexus of Inflammation-Induced Epithelial-Mesenchymal Transition and Lung Cancer Progression: A Roadmap to Pentacyclic Triterpenoid-Based Therapies.
Odarenko KV; Zenkova MA; Markov AV
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139154
[TBL] [Abstract][Full Text] [Related]
30. Small molecule inhibitors of epithelial-mesenchymal transition for the treatment of cancer and fibrosis.
Feng YL; Chen DQ; Vaziri ND; Guo Y; Zhao YY
Med Res Rev; 2020 Jan; 40(1):54-78. PubMed ID: 31131921
[TBL] [Abstract][Full Text] [Related]
31. Identification of protocatechuic acid as a novel blocker of epithelial-to-mesenchymal transition in lung tumor cells.
Yang MH; Baek SH; Chinnathambi A; Alharbi SA; Ahn KS
Phytother Res; 2021 Apr; 35(4):1953-1966. PubMed ID: 33251669
[TBL] [Abstract][Full Text] [Related]
32. PM2.5 induces EMT and promotes CSC properties by activating Notch pathway in vivo and vitro.
Wang Y; Zhong Y; Hou T; Liao J; Zhang C; Sun C; Wang G
Ecotoxicol Environ Saf; 2019 Aug; 178():159-167. PubMed ID: 31002970
[TBL] [Abstract][Full Text] [Related]
33. PTEN inactivation induces epithelial-mesenchymal transition and metastasis by intranuclear translocation of β-catenin and snail/slug in non-small cell lung carcinoma cells.
Perumal E; So Youn K; Sun S; Seung-Hyun J; Suji M; Jieying L; Yeun-Jun C
Lung Cancer; 2019 Apr; 130():25-34. PubMed ID: 30885348
[TBL] [Abstract][Full Text] [Related]
34. Implication of epithelial-mesenchymal transition in IGF1R-induced resistance to EGFR-TKIs in advanced non-small cell lung cancer.
Zhou J; Wang J; Zeng Y; Zhang X; Hu Q; Zheng J; Chen B; Xie B; Zhang WM
Oncotarget; 2015 Dec; 6(42):44332-45. PubMed ID: 26554308
[TBL] [Abstract][Full Text] [Related]
35. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
[TBL] [Abstract][Full Text] [Related]
36. Moscatilin inhibits epithelial-to-mesenchymal transition and sensitizes anoikis in human lung cancer H460 cells.
Busaranon K; Plaimee P; Sritularak B; Chanvorachote P
J Nat Med; 2016 Jan; 70(1):18-27. PubMed ID: 26384689
[TBL] [Abstract][Full Text] [Related]
37. Pirfenidone plays a biphasic role in inhibition of epithelial-mesenchymal transition in non-small cell lung cancer.
Fujiwara A; Shintani Y; Funaki S; Kawamura T; Kimura T; Minami M; Okumura M
Lung Cancer; 2017 Apr; 106():8-16. PubMed ID: 28285699
[TBL] [Abstract][Full Text] [Related]
38. The attenuation of epithelial to mesenchymal transition and induction of anoikis by gigantol in human lung cancer H460 cells.
Unahabhokha T; Chanvorachote P; Pongrakhananon V
Tumour Biol; 2016 Jul; 37(7):8633-41. PubMed ID: 26733180
[TBL] [Abstract][Full Text] [Related]
39. Potential function of oxymatrine as a novel suppressor of epithelial-to-mesenchymal transition in lung tumor cells.
Jung YY; Baek SH; Narula AS; Namjoshi OA; Blough BE; Ahn KS
Life Sci; 2021 Nov; 284():119893. PubMed ID: 34454947
[TBL] [Abstract][Full Text] [Related]
40. Blocking M2 muscarinic receptor signaling inhibits tumor growth and reverses epithelial-mesenchymal transition (EMT) in non-small cell lung cancer (NSCLC).
Zhao Q; Gu X; Zhang C; Lu Q; Chen H; Xu L
Cancer Biol Ther; 2015; 16(4):634-43. PubMed ID: 25778781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
